Opening on Florida's Atlantic coast brings the Company's Florida dispensary count to 79 and 189 nationwide
STAMFORD, Conn., Oct. 14, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the opening of a new Florida dispensary: Curaleaf Wellington, located at 2495 S State Road 7, Suite 101, Wellington, FL 33414. The new store increases the Company's Florida footprint to 79 dispensaries and its nationwide total to 189 stores.
Located in Palm Beach County, Curaleaf Wellington sits on State Road 7 in the Wellington Green commercial district, near The Mall at Wellington Green and the Forest Hill Boulevard intersection, putting it within easy reach of patients in Wellington, Royal Palm Beach, Greenacres, and Lake Worth. Home to more than 61,000 residents, the Village of Wellington is best known as a world-class equestrian destination. Each winter, Wellington International hosts the Winter Equestrian Festival, the largest and longest-running horse show in the world, while the village's 9,000-acre Equestrian Preserve protects the polo fields, show grounds, and more than 100 miles of public bridle trails that define daily life there. That identity carries into the store itself, where a custom mural features locally inspired artwork celebrating the community and its equestrian heritage. The store will offer a wide range of products, including Curaleaf's Florida-exclusive Reef flower, Dark Heart ultra-premium flower, FIND flower, Anthem pre-rolls, and the Select Briq 2 all-in-one vape.
"Florida is one of the most important medical cannabis markets in the country, and its patient community keeps growing," said Boris Jordan, Chairman and CEO of Curaleaf. "Every new store we open is a commitment to grow alongside that community. With Wellington, we're bringing reliable care and high-quality products closer to home for more patients across Palm Beach County."
A grand opening celebration will take place at Curaleaf Wellington on Friday, October 16 and Saturday, October 17, beginning at 9:00 A.M. ET both days. The celebration will feature special promotions, giveaways, and in-store activations. Promotional offers include a spend-and-get pre-roll offer, a free eighth for the first 25 patients with a qualifying medical card each day, and a free 0.5g Curaleaf 510 cartridge with a qualifying purchase.
Curaleaf Wellington will operate Monday through Saturday from 9:00 A.M. to 8:30 P.M. ET, and Sunday from 10:00 A.M. to 7:00 P.M. ET. For more information about Curaleaf's Florida dispensaries, products, and patient resources, please visit https://curaleaf.com/dispensary/florida.
About Curaleaf Holdings
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, FIND, Dark Heart, and Anthem, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.
Forward-Looking Statements
This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning the opening of a dispensary in Wellington, Florida. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this news release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and uncertainties is discussed in the Company's Form 8-K dated August 5, 2026 together with the annual report on Form 10-K for the year ended December 31, 2025 and the quarterly report on Form 10-Q for the quarter ended March 31, 2026, attached as exhibits thereto, as well as the Form 10-Q for the quarter ended June 30, 2026, each of which documents have been filed on the Company's EDGAR profile atwww.sec.gov/edgar and SEDAR+ profile atwww.sedarplus.ca, and as described from time to time in documents filed by the Company with the U.S. Securities and Exchange Commission and the Canadian securities regulatory authorities. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Toronto Stock Exchange has not reviewed, approved or disapproved the content of this news release.
Investor Contact:
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment Officer
IR@curaleaf.com
Media Contact:
MATTIO Communications
MattioCuraleaf@Mattio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/curaleaf-continues-florida-expansion-with-wellington-dispensary-opening-302908058.html
SOURCE Curaleaf Holdings, Inc.
